期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 13, 期 1, 页码 5-10出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.1c00617
关键词
flavivirus; virus-targeting; host-targeting; emerging virus
资金
- Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigacion [PID2019-105117RR-C22, PID2019-105117RR-C21, MCIN/AEI/10.13039/501100011033]
This viewpoint discusses the advantages and disadvantages of virus-targeting antivirals and host-targeting drugs as potential therapies for Flavivirus infections. These two approaches may be complementary, each with its own strengths and weaknesses.
The COVID pandemic has evidenced how vulnerable we are to emerging infectious diseases and how short our current armamentarium is. Flavivirus, single stranded RNA viruses transmitted by arthropods, are considered a global health challenge. No drugs to treat these infections have been approved. In this Viewpoint, we analyze the advantages and disadvantages of two different, but probably also complementary, therapeutic approaches: virus-targeting antivirals and host-targeting drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据